Cantor Fitzgerald Maintains Overweight on Eli Lilly and Co, Raises Price Target to $885
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen maintains an Overweight rating on Eli Lilly and Co (LLY) and raises the price target from $815 to $885.
May 01, 2024 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reaffirmed an Overweight rating on Eli Lilly and raised the price target from $815 to $885.
The increase in the price target by a reputable analyst suggests a strong bullish outlook on Eli Lilly, likely leading to positive investor sentiment and a potential short-term increase in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100